0-9 a b c d e f g h i j k l m n o p q r s t u v w y z search

TeachMeFinance.com - explain polyethylene glycosylated recombinant human megakaryocyte growth and development factor polyethylene glycosylated recombinant human megakaryocyte growth and development factor -- (PAH-lee-EH-thuh-leen gly-KAH-sih-layt-id ree-KAHM-bih-nunt HYOO-mun MEH-guh-KAH-ree-oh-site �c) PEG-rhMGDF. A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. Polyethylene glycosylated recombinant human megakaryocyte growth and development factor is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-MGDF. About the author Mark McCracken Author: Mark McCracken is a corporate trainer and author living in Higashi Osaka, Japan. He is the author of thousands of online articles as well as the Business English textbook, "25 Business Skills in English". Copyright © 2005 by Mark McCracken, All Rights Reserved. TeachMeFinance.com is an informational website, and should not be used as a substitute for professional medical, legal or financial advice. Information presented at TeachMeFinance.com is provided on an "AS-IS" basis. Source of definition: The National Cancer Institute. Please read the disclaimer for details.